Treatment options for patients with glioblastoma multiforme (GBM), the most common form of malignant gliomas, now include anti-angiogenic therapy after failure of standard multi-modality treatments.
Work is being done on tumor specific agents that attack only cancer cells. Anti-angiogenic drugs - Anti-angiogenic drugs contain organic or synthetic molecules that can block the formation of new ...
Traditional anti-VEGF therapies mainly target immature blood vessels in tumors. Currently, it is predicted that the combinational targeting of both VEGF and ANGPT2 pathways enhances clinical ...